Biotech Stocks ImmunoGen, BeiGene Surge to New Highs

A new stake from Celgene has BeiGene at record highs

Jul 6, 2017 at 10:31 AM
facebook X logo linkedin

Analysts are weighing in on biotech stocks ImmunoGen, Inc. (NASDAQ:IMGN) and BeiGene Ltd (ADR) (NASDAQ:BGNE), as well as coffee giant Starbucks Corporation (NASDAQ:SBUX). Here's a quick roundup of today's bullish brokerage notes on shares of IMGN, BGNE, and SBUX.

RBC Sets Major Price Target for IMGN Stock

ImmunoGen stock is up 8% at $7.88 today, and earlier touched an annual high of $8.04, after RBC raised its rating to "outperform" from "sector perform," while also boosting its price target to $12 from $5. This represents territory not seen for IMGN since January 2016, though the shares are up 281% year-to-date. Short sellers have been piling on amid this surge. Specifically, short interest jumped 18% over the past two reporting periods, and now represents 16% of Immunogen's float. 

BeiGene Stock Hits Record High on Celgene News

BeiGene stock has rallied 15.8% to trade at $60.55, and earlier hit a record high of  $68.67, thanks to news Celgene will buy a stake in the company and help it develop its cancer treatment. BGNE stock has had a great year on the charts, more than doubling in value. Most analysts are already bullish, with all four in coverage rating the stock a "buy" or "strong buy." Just this morning, in fact, Maxim raised its price target to $57 from $52. 

SBUX Stock Dips Despite Bull Note

Starbucks stock is down 0.6% at $57.61, despite a Mizuho Securities analyst reiterating a "buy" recommendation amid signs of "substantial growth in mobile order adoption." However, Muslim groups in Malaysia have aligned with protesters in Indonesia, calling for a boycott of the coffee chain over its support of LGBT rights. SBUX stock touched a record high of $64.87 about a month ago, but has since pulled back to float just above its 200-day moving average. The equity's 14-day Relative Strength Index (RSI) is now at 30 -- on the cusp of oversold territory.

Starbucks sports a Schaeffer's put/call open interest ratio (SOIR) of 1.19, in the 87th percentile of its annual range. This means near-term options traders have rarely been more put-heavy on SBUX stock.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI